Clinical trial No longer in our active list Observational Ages 18 and up

Examining silicone particles in breast implant capsules

Official title: Silicone Particles in Breast Implant Capsules: a Retrospective Monocentric Study Evaluation of Silicone Bleeding

Run by Brugmann University Hospital · NCT06257251 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study looks at whether tiny silicone particles in the capsules around breast implants cause inflammation and complications like pain and lumps in patients who had their implants revised.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment65 (estimated)
SponsorBrugmann University Hospital
Academic / other
Locations1 site (Brussels)
Trial IDNCT06257251 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients who have undergone surgical revision of breast implants at CHU-Brugmann Hospital within the specified timeframe.

Probably not a fit

Patients who have not had breast implants or those who have not undergone surgical revision at the specified hospital will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the presence of silicone particles in the capsules surrounding breast implants, which can occur due to silicone leakage. It aims to understand the inflammatory response triggered by these particles, which may lead to complications such as granuloma formation and breast pain. The study involves digitizing histological slides from patients who underwent surgical revision of their breast implants at CHU-Brugmann Hospital between January 2013 and October 2023. By analyzing these samples, researchers hope to gain insights into the biological effects of silicone particles on surrounding tissues.

Why it matters

Potential benefit: If successful, this study could enhance understanding of complications related to breast implants and improve patient management strategies.

How similar studies have gone: While there have been studies on silicone implants, this specific focus on silicone particles and their inflammatory effects is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients admitted and operated at CHU-Brugmann Hospital (Horta \& Brien)
* Surgery between January 2013 and October 2023
* Type of surgery: surgical revision of their breast implants requiring partial or complete sampling of the peri-prosthetic capsule.

Exclusion Criteria:

- None

Where it's running

  • CHU Brugmann
    Brussels, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.